Ind-Swift Laboratories Ltd
₹131.86
as on
Ind-Swift Laboratories Stock Performance
as on April 17, 2026 at 9:31 pm IST
Day's Low
Day's High
₹127.30₹143.30
3.46%
Downside
8.68%
Upside
52 Week's Low
52 Week's High
₹68.72₹156.8047.88%
Downside
18.91%
Upside
Ind-Swift Laboratories share price movements today
- Previous Close
- ₹145.41
- Open
- ₹136.00
- Volume
- 1.35Cr
- Upper Circuit
- ₹174.49
- Lower Circuit
- ₹116.33
- Day's Low - High
- ₹127.30 - ₹143.30
- 52 Week Low - High
- ₹68.72 - ₹156.80
Ind-Swift Laboratories Historical Returns
- 1 Month Return
- -9.31 %
- 3 Month Return
- + 18.32 %
- 1 Year Return
- + 54.08 %
- 3 Year Return
- + 102.24 %
- 5 Year Return
- + 88.91 %
Ind-Swift Laboratories Fundamentals
as on April 17, 2026 at 4:01 pm IST
Market Cap
₹1,145.03 Cr
Return on Equity (ROE)
0.64
PE Ratio (TTM)
3.62
Return on capital employed (ROCE)
1.09
Industry PE ratio
41.98
Beta (LTM)
1.09
P/B Ratio
0.53
Dividend Yield
0PEG Ratio
-0.08
Quarterly Earnings Growth YOY
-273.09
EPS (TTM)
36.44
Sector
Pharmaceuticals
Book Value
159.86
Technical Analysis
Bearish
View Technical Analysis
Ind-Swift Laboratories Stock Valuation
as on April 17, 2026 at 4:01 pm IST
Ind-Swift Laboratories in the last 5 years
Lowest (-1795.00x)
December 8, 2022
Today (3.62x)
April 17, 2026
Industry (41.98x)
April 17, 2026
Highest (64.97x)
July 19, 2021
Today’s Price to Earnings Ratio: 3.62x
Ind-Swift Laboratories Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Ind-Swift Laboratories with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 1,145.03 | 17.78% | 0.52 | 250 | 561 | |
| NA | 1,578.99 | 1877.89% | 0.00 | 9 | 32 | |
| BUY | 4,803.24 | -1.45% | 1.88 | -343 | 71 | |
| NA | 162.62 | 40.48% | 0.00 | 13 | 107 | |
| NA | 1,960.98 | 208.61% | 0.51 | 18 | 156 |
Ind-Swift Laboratories Stock’s Investor Sentiment and Interest
Search interest for Ind-Swift Laboratories Ltd Stock has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Ind-Swift Laboratories Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Ind-Swift Laboratories Ltd Annual Profit & Loss
Figures in Rupees Crores
Ind-Swift Laboratories Ltd Cash Flow
Figures in Rupees Crores
Ind-Swift Laboratories Corporate Actions
View detailed summary of the earnings and dividend history of Ind-Swift Laboratories.
Ind-Swift Laboratories Ltd Earnings Results
Ind-Swift Laboratories Ltd’s net profit jumped 273.77% since last year same period to ₹9.54Cr in the Q3 2025-2026. On a quarterly growth basis, Ind-Swift Laboratories Ltd has generated 19.4% jump in its net profits since last 3-months.
Read More about Earnings ResultsInd-Swift Laboratories Ltd Dividends May,2011
In the quarter ending March 2011, Ind-Swift Laboratories Ltd has declared dividend of ₹1.00 per share on 25 May 2011 - translating a dividend yield of 1.52%.
Read More about Dividends
Insights on Ind-Swift Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, INDSWFTLAB has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 7.99 Cr → 9.54 Cr (in ₹), with an average increase of 16.3% per quarter
- POSITIVE IMPACT
Promoter Holding Up
Promoters have increased holdings from 39.50% to 43.06% in Feb 2026 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 167.32 Cr → 178.43 Cr (in ₹), with an average increase of 3.2% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Lupin Ltd has given 233.0% return, outperforming this stock by 130.8%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 14.33% to 13.80% in Feb 2026 quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, INDSWFTLAB stock has moved down by -5.2%
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 45.50% to 42.98% in Feb 2026 quarter
About Ind-Swift Laboratories Ltd
Revenue: ₹150.85Cr as on December 2025 (Q3 FY26)
Net Profit: ₹9.52Cr as on December 2025 (Q3 FY26)
Listing date: 02 Jul, 1997
Chairperson Name: N R Munjal
| Organisation | Ind-Swift Laboratories Ltd |
| Headquarters | Chandigarh |
| Industry | Pharmaceuticals |
| CEO | N R Munjal |
| E-voting on shares | Click here to vote |
FAQs
What is Ind-Swift Laboratories share price today?
Ind-Swift Laboratories share price today stands at ₹131.86 as on at the close of the market. Ind-Swift Laboratories share today touched a day high of ₹143.3 and a low of ₹127.3.
What is the 52 week high and 52 week low range for Ind-Swift Laboratories share?
Ind-Swift Laboratories touched a 52 week high of ₹156.8 and a 52 week low of ₹68.72. Ind-Swift Laboratories share price today i.e. is closed at ₹131.86, which is -15.91% down from its 52 week high and 91.88% up from its 52 week low.
What is Ind-Swift Laboratories's market capitalisation today?
Ind-Swift Laboratories market capitalisation is ₹1,145.03 Cr as on .
How to buy Ind-Swift Laboratories shares?
To buy Ind-Swift Laboratories shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for INDSWFTLAB or Ind-Swift Laboratories Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Ind-Swift Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Ind-Swift Laboratories trading volume today?
Ind-Swift Laboratories trading volume is 1.35Cr as on . This means that 1.35Cr shares of Ind-Swift Laboratories were bought and sold on the stock market during today's trading session.